Huida Biotech
Zhejiang Huida Biotech Co., LTD. is a Hangzhou China based company, subsidiary of Huadong Medicine Co., Ltd.. Huida focuses on R&D and commercial supply of high quality ADC payloads and linkers using microorganism and/or synthesis technology, such as: Exatecan mesylate (US DMF submitted with No. MF036614), DM1(US DMF submitted with No. MF037293), MMAE (US DMF to be submitted in Q2 of 2023), Ansamitocin P-3 (US DMF to be submitted as intended), Ansamitocin P-0 (US DMF to be submitted as intended), Calicheamicin (US DMF to be submitted as intended) other intermediates and derivatives.
Huida also provides customerization services with regulatory support including full quality study to the customers.
